Author： Bayraktar Soley
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.17, Iss.4, 2012-12, pp. : 571-582
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cell-cycle dysregulation and anticancer therapy
By Stewart Z.A. Westfall M.D. Pietenpol J.A.
Trends in Pharmacological Sciences, Vol. 24, Iss. 3, 2003-03 ,pp. :
Access to resources
Recommend
MDM2 Inhibitors for Pancreatic Cancer Therapy
Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 6, 2010-06 ,pp. :
Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-04 ,pp. :
Emerging pathways and future targets for the molecular therapy of pancreatic cancer
By Vaccaro Vanja Melisi Davide Bria Emilio Cuppone Federica Ciuffreda Ludovica Pino Maria Simona Gelibter Alain Tortora Giampaolo Cognetti Francesco Milella Michele
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. :